Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $3.5 million.

  • Angiodynamics' Free Cash Flow rose 16447.67% to $3.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$9.6 million, marking a year-over-year increase of 6346.31%. This contributed to the annual value of -$14.6 million for FY2025, which is 5243.19% up from last year.
  • Per Angiodynamics' latest filing, its Free Cash Flow stood at $3.5 million for Q4 2025, which was up 16447.67% from -$16.7 million recorded in Q3 2025.
  • Over the past 5 years, Angiodynamics' Free Cash Flow peaked at $18.2 million during Q2 2025, and registered a low of -$27.0 million during Q3 2022.
  • Moreover, its 5-year median value for Free Cash Flow was $599500.0 (2023), whereas its average is -$2.9 million.
  • Per our database at Business Quant, Angiodynamics' Free Cash Flow surged by 90875.16% in 2022 and then tumbled by 1241363.64% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Free Cash Flow stood at -$777000.0 in 2021, then soared by 908.75% to $6.3 million in 2022, then tumbled by 35.53% to $4.1 million in 2023, then tumbled by 67.69% to $1.3 million in 2024, then soared by 164.48% to $3.5 million in 2025.
  • Its Free Cash Flow was $3.5 million in Q4 2025, compared to -$16.7 million in Q3 2025 and $18.2 million in Q2 2025.